139 related articles for article (PubMed ID: 36566524)
1. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats.
González-Correa C; Moleón J; Miñano S; Robles-Vera I; Toral M; Martín-Morales N; O'Valle F; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Biomed Pharmacother; 2023 Feb; 158():114149. PubMed ID: 36566524
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats.
Robles-Vera I; de la Visitación N; Toral M; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Biomed Pharmacother; 2021 Mar; 135():111189. PubMed ID: 33388596
[TBL] [Abstract][Full Text] [Related]
3. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects.
Robles-Vera I; Toral M; de la Visitación N; Sánchez M; Gómez-Guzmán M; Muñoz R; Algieri F; Vezza T; Jiménez R; Gálvez J; Romero M; Redondo JM; Duarte J
Br J Pharmacol; 2020 May; 177(9):2006-2023. PubMed ID: 31883108
[TBL] [Abstract][Full Text] [Related]
4. Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats.
Toral M; Robles-Vera I; de la Visitación N; Romero M; Sánchez M; Gómez-Guzmán M; Rodriguez-Nogales A; Yang T; Jiménez R; Algieri F; Gálvez J; Raizada MK; Duarte J
Acta Physiol (Oxf); 2019 Sep; 227(1):e13285. PubMed ID: 31004464
[TBL] [Abstract][Full Text] [Related]
5. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs.
González-Correa C; Moleón J; Miñano S; Robles-Vera I; Toral M; Barranco AM; Martín-Morales N; O'Valle F; Guerra-Hernández E; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Br J Pharmacol; 2024 May; ():. PubMed ID: 38770714
[TBL] [Abstract][Full Text] [Related]
6. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
[TBL] [Abstract][Full Text] [Related]
7. Probiotics Prevent Dysbiosis and the Rise in Blood Pressure in Genetic Hypertension: Role of Short-Chain Fatty Acids.
Robles-Vera I; Toral M; de la Visitación N; Sánchez M; Gómez-Guzmán M; Romero M; Yang T; Izquierdo-Garcia JL; Jiménez R; Ruiz-Cabello J; Guerra-Hernández E; Raizada MK; Pérez-Vizcaíno F; Duarte J
Mol Nutr Food Res; 2020 Mar; 64(6):e1900616. PubMed ID: 31953983
[TBL] [Abstract][Full Text] [Related]
8. Curcumin ameliorates hypertension via gut-brain communication in spontaneously hypertensive rat.
Li HB; Xu ML; Du MM; Yu XJ; Bai J; Xia WJ; Dai ZM; Li CX; Li Y; Su Q; Wang XM; Dong YY; Kang YM
Toxicol Appl Pharmacol; 2021 Oct; 429():115701. PubMed ID: 34453990
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.
Xiong Y; He Y; Chen Z; Wu T; Xiong Y; Peng Y; Yang X; Liu Y; Zhou J; Zhou H; Zhang W; Shu Y; Li X; Li Q
J Hypertens; 2024 Mar; 42(3):460-470. PubMed ID: 38009301
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat.
Xia WJ; Xu ML; Yu XJ; Du MM; Li XH; Yang T; Li L; Li Y; Kang KB; Su Q; Xu JX; Shi XL; Wang XM; Li HB; Kang YM
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33382364
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the gut microbiota can elicit hypertension in rats.
Adnan S; Nelson JW; Ajami NJ; Venna VR; Petrosino JF; Bryan RM; Durgan DJ
Physiol Genomics; 2017 Feb; 49(2):96-104. PubMed ID: 28011881
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate Improves Brain-Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats.
Robles-Vera I; de la Visitación N; Sánchez M; Gómez-Guzmán M; Jiménez R; Moleón J; González-Correa C; Romero M; Yang T; Raizada MK; Toral M; Duarte J
Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33260593
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the mineralocorticoid receptor in the brain of spontaneously hypertensive rats.
Pietranera L; Brocca ME; Cymeryng C; Gomez-Sanchez E; Gomez-Sanchez CE; Roig P; Lima A; De Nicola AF
J Neuroendocrinol; 2012 Sep; 24(9):1249-58. PubMed ID: 22564091
[TBL] [Abstract][Full Text] [Related]
14. Kefir ameliorates hypertension via gut-brain mechanisms in spontaneously hypertensive rats.
de Almeida Silva M; Mowry FE; Peaden SC; Andrade TU; Biancardi VC
J Nutr Biochem; 2020 Mar; 77():108318. PubMed ID: 31923755
[TBL] [Abstract][Full Text] [Related]
15. Selective IgA Deficiency in Spontaneously Hypertensive Rats With Gut Dysbiosis.
Saha P; Mell B; Golonka RM; Bovilla VR; Abokor AA; Mei X; Yeoh BS; Doris PA; Gewirtz AT; Joe B; Vijay-Kumar M
Hypertension; 2022 Oct; 79(10):2239-2249. PubMed ID: 35950503
[TBL] [Abstract][Full Text] [Related]
16. Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats.
Dong S; Liu Q; Zhou X; Zhao Y; Yang K; Li L; Zhu D
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677668
[TBL] [Abstract][Full Text] [Related]
17. Critical Role of the Interaction Gut Microbiota - Sympathetic Nervous System in the Regulation of Blood Pressure.
Toral M; Robles-Vera I; de la Visitación N; Romero M; Yang T; Sánchez M; Gómez-Guzmán M; Jiménez R; Raizada MK; Duarte J
Front Physiol; 2019; 10():231. PubMed ID: 30930793
[TBL] [Abstract][Full Text] [Related]
18.
Lu W; Wang Y; Fang Z; Wang H; Zhu J; Zhai Q; Zhao J; Zhang H; Chen W
Food Funct; 2022 Jun; 13(11):6373-6386. PubMed ID: 35615892
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the gut microbial community structure and function with aging in the spontaneously hypertensive stroke prone rat.
Shi H; Nelson JW; Phillips S; Petrosino JF; Bryan RM; Durgan DJ
Sci Rep; 2022 May; 12(1):8534. PubMed ID: 35595870
[TBL] [Abstract][Full Text] [Related]
20. Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats.
Cezar MD; Damatto RL; Pagan LU; Lima AR; Martinez PF; Bonomo C; Rosa CM; Campos DH; Cicogna AC; Gomes MJ; Oliveira SA; Blotta DA; Okoshi MP; Okoshi K
Cell Physiol Biochem; 2015; 36(4):1453-66. PubMed ID: 26160286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
